New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival <i>via</i> suppression of TXNIP/NLRP3 pyroptosis signaling in Streptozocin-Induced diabetes mellitestype-1 in rats.

Heliyon · 2024 · PMC11620097 · PMID 39640632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Notably, combining liraglutide and/or probiotic with BCG showed a highly significant increase in all these morphometric parameters when compared to BCG monotherapy in group 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.